Roel Bulthuis - Profile and Investment Details

Investor Profile

Roel Bulthuis is a Venture Capital, Private Equity Firm, Investor based in Amsterdam, North Holland, The Netherlands with a diverse investment portfolio that includes companies such as Sapiens Steering Brain Stimulation, Salvia BioElectronics, Quantum Motion Technologies, Happeo, Nightbalance, F-Star Therapeutics, Silverflow, NPEX, Blendle, Lanthio Pharma, Scenic Biotech, VarmX, Serono International, M Ventures, ChannelEngine, WerckerGeoPhy, iOnctura, Draupnir Bio, ViCentra, NMD Pharma, Health Value Creation, Lengoo, Calypso Biotech, Polarsteps, QurAlis, InteRNA Technologies, Aidence, Urban Sports Club, Audion Therapeutics, Robin Radar Systems, Castor, GTX medical, Fortis Bank, Bird Rock Bio, INKEF Capital, ProFibrix, Comet Therapeutics, Aito, Rainier Therapeutics, Cashforce, Withlocals, OneFit, aveni, EclecticIQ, Bloomon, Remote, Merck Serono, GitLab, Shapeways, Crowdynews, . Over time, Roel Bulthuis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Roel Bulthuis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Advertising, Health Care, E-commerce, Cybersecurity, Wellness, Immunotherapy, Rare Diseases, Healthcare Innovation, Life Science, Engineering, Portfolio Management, Artificial Intelligence (AI), Retail, Information Technology (IT), Marketplace, Software, Biotechnology, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, FinTech, Consumer Internet, Gene Therapy, Mergers and Acquisitions, Social Impact, Digital Health, Medical, SaaS, B2B, Therapeutics, Cellular Therapy, Machine Learning, Pharmaceuticals, Healthcare Technology, Risk Management, Acquisitions, Translation Service may find it worthwhile to explore potential connections with Roel Bulthuis, as their portfolio suggests a familiarity and interest in this area.

Understanding Roel Bulthuis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.